GLP-1 patches and oral liquid formulations represent additional delivery innovations that naturally provide more stable drug levels through continuous or frequent dosing
KW, JW, and JHZ wrote the manuscript and finalized the paper
However, a relationship between disease and mutation of the human CPTI gene has not been reported [47]
doi: 10.3389/fendo.2024.1332702 Received 03 November 2023 Accepted 15 January 2024 Published 02 February 2024 Volume 15 - 2024 Edited by Tongzhi Wu, University of Adelaide, Australia Reviewed by Cong Xie, Royal Adelaide Hospital, Australia Ryan Jalleh, University of Adelaide, Australia Updates Copyright 2024 Younes, Cron, Field, Nayyar, Clark, Zachariah, Lakshmipathy, Isuga, Maghsoodi and Emmanuel
Energy expenditure and plateau mechanisms in semaglutide users
Some studies suggest GLP-1 medications may improve testosterone levels, potentially benefiting sexual health, while a 2025 analysis of US Food and Drug Administration data identified 185 reports of sexual dysfunction, particularly among men taking GLP-1 receptor agonists
